Flexion

3 Biotechs Launching Their First Commercial Drugs in 2018
3 Biotechs Launching Their First Commercial Drugs in 2018
Motley Fool
biotech
drug launches
Flexion
Zilretta
osteoarthritis of the knee
La Jolla Pharmaceutical
Giapreza
shock
Portola Pharmaceuticals
Bevyxxa
venous thromboembolism
Flag link:
A newly approved drug could shake up how doctors treat knee pain
A newly approved drug could shake up how doctors treat knee pain
Motley Fool
Flexion
Zilretta
osteoarthritis of the knee
Flag link:
After FDA nod, Flexion launches osteoarthritis injection
After FDA nod, Flexion launches osteoarthritis injection
Drug Delivery Business News
FDA
Flexion
osteoarthritis of the knee
Zilretta
drug launch
Flag link:
Flexion nabs FDA OK for its potential blockbuster osteoarthritis drug, triggering new buyout buzz
Flexion nabs FDA OK for its potential blockbuster osteoarthritis drug, triggering new buyout buzz
Endpoints
Flexion
FDA
osteoarthritis
M&A
Zilretta
Flag link:
3 Biotech Stocks With Big News Coming
3 Biotech Stocks With Big News Coming
Motley Fool
biotech
Flexion
Zilretta
osteoarthritis of the knee
Zogenix
ZX008
Dravet syndrome
Keryx
chronic kidney disease
Auryxia
Flag link:
With an FDA decision looming, Flexion touts new data spotlighting a safety edge for osteoarthritis drug
With an FDA decision looming, Flexion touts new data spotlighting a safety edge for osteoarthritis drug
Endpoints
FDA
Flexion
Zilretta
osteoarthritis
Flag link:
[video]Can Drugmakers Cure the Opioid Crisis?
[video]Can Drugmakers Cure the Opioid Crisis?
Motley Fool
opioids
opioid abuse
opioid crisis
Pacira
Cara Therapeutics
Nektar
Flexion
Flag link:
Sanofi Buying Flexion: A Smart Move?
Sanofi Buying Flexion: A Smart Move?
Motley Fool
Sanofi
Flexion
M&A
osteoarthritis of the knee
Flag link:
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source
Fierce Pharma
Sanofi
Flexion
M&A
osteoarthritis of the knee
Zilretta
Flag link:
Top Biotech Stocks With FDA Decisions in 2017
Top Biotech Stocks With FDA Decisions in 2017
Motley Fool
FDA
Flexion
Zilretta
knee pain
osteoarthritis
neratinib
Puma Biotechnology
breast cancer
Portola
betrixaban
bloodthinners
Flag link:
3 Drugs Heading to the FDA Soon
3 Drugs Heading to the FDA Soon
Motley Fool
FDA
Kite Pharma
KTE-C19
Flexion
Zilretta
AG-221
Agios Pharmaceuticals
Celgene
Flag link:
Trial suggests Flexion’s knee injection may be safer for diabetes patients
Trial suggests Flexion’s knee injection may be safer for diabetes patients
Bizjournals.com
Flexion
diabetes
Zilretta
osteoarthritis of the knee
Flag link:
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Motley Fool
biotech
FDA
Aerie Pharma
Rhopressa
Flexion
Zilretta
Puma Biotechnology
neratinib
Flag link:
Flexion's pain drug comes through in Phase III after a prior pivotal failure
Flexion's pain drug comes through in Phase III after a prior pivotal failure
Fierce Biotech
Flexion
painkillers
osteoarthritis
FX006
Flag link:
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Yahoo/Benzinga
biotech
Gilead Sciences
Akebia
Vitae
Clovis Oncology
AstraZeneca
Bristol-Myers Squibb
Flexion
Tetraphase Pharmaceuticals
Flag link:
FDA lifts hold on Flexion's lead drug
FDA lifts hold on Flexion's lead drug
Yahoo/Reuters
FDA
Flexion
FX006
osteoarthritis
Flag link:
Flexion tanks as FDA clamps a hold on its lead osteoarthritis drug
Flexion tanks as FDA clamps a hold on its lead osteoarthritis drug
Fierce Biotech
FDA
Flexion
osteoarthritis of the knee
FX0006
Flag link:
Flexion Therapeutics Is On A Potentially Accelerated Path For Osteoarthritis Drug
Flexion Therapeutics Is On A Potentially Accelerated Path For Osteoarthritis Drug
Seeking Alpha
Flexion
osteoarthritis of the knee
Flag link:
Biotechs pocket another $115M as the IPO boom thunders on
Biotechs pocket another $115M as the IPO boom thunders on
Fierce Biotech
biotech
IPOs
Flexion
Eagle Pharmaceuticals
Flag link:
Flexion lands $42M, acquires drug targets
Flexion lands $42M, acquires drug targets
bizjournals
Flexion
Pfizer
AstraZeneca
Merck Serono
Flag link: